Legend Biotech Corp
NASDAQ:LEGN

Watchlist Manager
Legend Biotech Corp Logo
Legend Biotech Corp
NASDAQ:LEGN
Watchlist
Price: 23.26 USD -2.6%
Market Cap: 4.3B USD

P/E
Price to Earnings

-17.8
Current
-24.8
Median
24
Industry
Higher than median
Lower than industry value

The Price to Earnings (P/E) ratio shows how much investors are willing to pay for each dollar of a company’s earnings. It’s calculated by dividing the company’s market value by its net income.

P/E
-17.8
=
Market Cap
4.3B USD
/
Net Income
-240m USD
All Countries
Close
Earnings Growth PEG
US
Legend Biotech Corp
NASDAQ:LEGN
Average P/E: 193.9
Negative Multiple: -17.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 126.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.3
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.4
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.2
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.4
9%
1.8
AU
CSL Ltd
ASX:CSL
19.5
11%
1.8
NL
argenx SE
XBRU:ARGX
35.7
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 238.9
N/A N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-24.4
2-Years Forward
P/E
49.5
3-Years Forward
P/E
16.5